SCIENTURE HOLDINGS, INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
SCIENTURE HOLDINGS, INC. (SCNX) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $288.98 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2018-03-02
- SCIENTURE HOLDINGS, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2017 was $288.98K.
- SCIENTURE HOLDINGS, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2016 was -$2.76M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|
| 2017-12-31 | $288.98K 10-K · filed 2018-03-02 |
| 2016-12-31 | -$2.76M 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |